Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Ida T, Furuta S, Fujiwara M, Hiraguri M, Hirose K, Ikeda K, Iwamoto T, Kagami SI, Kobayashi Y, Kurasawa K, Nakagomi D, Oya Y, Sanayama Y, Shimizu T, Tamachi T, Umibe T, Yasui M, Nakajima H. Ida T, et al. Among authors: kurasawa k. Rheumatology (Oxford). 2024 Jan 12:keae011. doi: 10.1093/rheumatology/keae011. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38216799
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T; Japan Biological Agent Study Integrated Consortium. Kameda H, et al. Mod Rheumatol. 2010 Dec;20(6):531-8. doi: 10.1007/s10165-010-0324-4. Epub 2010 Jun 24. Mod Rheumatol. 2010. PMID: 20574649 Clinical Trial.
Risk factors for positive cervical cytology during early pregnancy screening and awareness of positive cytological results in Japan: a report from the Pregnant Women Health Initiative.
Ushio E, Mizushima T, Sukegawa A, Saigusa Y, Kurasawa K, Iwata A, Aoki S, Ueda Y, Sekine M, Miyagi E. Ushio E, et al. Among authors: kurasawa k. J Int Med Res. 2024 Oct;52(10):3000605241285548. doi: 10.1177/03000605241285548. J Int Med Res. 2024. PMID: 39495189 Free PMC article.
Global health systems strengthening: FIGO's strategic view on reducing maternal and newborn mortality worldwide.
Miranda J, Miller S, Alfieri N, Lalonde A, Ivan-Ortiz E, Hanson C, Steinholt M, Palshetkar N, Suharjono H, Gebhardt S, Dossou JP, Pascali-Bonaro D, Jacobsson B, Okong P; FIGO Committee on Health Systems Strengthening and Respectful Care. Miranda J, et al. Int J Gynaecol Obstet. 2024 Jun;165(3):849-859. doi: 10.1002/ijgo.15553. Epub 2024 Apr 23. Int J Gynaecol Obstet. 2024. PMID: 38651311 Review.
Difficulty in Serologic Screening for Subclinical Rubella during Pregnancy.
Hiiragi K, Shindo R, Shinoda S, Okuda M, Tanaka-Taya K, Kurasawa K, Miyagi E, Aoki S. Hiiragi K, et al. Among authors: kurasawa k. Jpn J Infect Dis. 2024 Mar 21;77(2):91-96. doi: 10.7883/yoken.JJID.2023.222. Epub 2023 Nov 30. Jpn J Infect Dis. 2024. PMID: 38030270 Free article.
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS collaborators. Furuta S, et al. Among authors: kurasawa k. Ann Rheum Dis. 2024 Jan 2;83(1):96-102. doi: 10.1136/ard-2023-224343. Ann Rheum Dis. 2024. PMID: 37734880 Clinical Trial.
140 results